This inventor holds 1 USPTO granted patent. Top assignee: Diazyme Laboratories, Inc.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Abhijit Datta: Innovator in Antibody Assay Technologies
Introduction
Abhijit Datta is a prominent inventor based in San Diego, California. He has made significant contributions to the field of biotechnology, particularly in the analysis of neutralizing antibodies related to SARS-CoV-2. His work is crucial in understanding and combating coronavirus infections.
Latest Patents
Abhijit Datta holds a patent for "Compositions and methods for assaying neutralizing antibodies." This patent provides compositions and methods for analyzing neutralizing antibodies to SARS-CoV-2. It is particularly useful for samples from subjects suspected of having, having, or having had a SARS-CoV-2 infection, as well as for those who have received therapeutic interventions for coronavirus infections. He has 1 patent to his name.
Career Highlights
Abhijit Datta is currently employed at Diazyme Laboratories, Inc., where he continues to innovate in the field of antibody assays. His work at Diazyme Laboratories has positioned him as a key player in the development of diagnostic tools for infectious diseases.
Collaborations
Abhijit has collaborated with notable colleagues, including Chong-Sheng Yuan and Fakhri B Saida. These collaborations have further enhanced the impact of his research and innovations in the biotechnology sector.
Conclusion
Abhijit Datta's contributions to the field of biotechnology, particularly in the area of neutralizing antibody assays, highlight his role as an important inventor. His work is vital for advancing our understanding of coronavirus infections and improving diagnostic methods.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile